These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 9987797)

  • 1. Ocular delivery systems of pefloxacin mesylate.
    Bharath S; Hiremath SR
    Pharmazie; 1999 Jan; 54(1):55-8. PubMed ID: 9987797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ocular inserts for controlled delivery of pefloxacin mesylate: preparation and evaluation.
    Sultana Y; Aqil M; Ali A
    Acta Pharm; 2005 Sep; 55(3):305-14. PubMed ID: 16375841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and evaluation of ocular drug delivery system.
    Gorle AP; Gattani SG
    Pharm Dev Technol; 2010; 15(1):46-52. PubMed ID: 19552545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ion-activated, Gelrite-based in situ ophthalmic gels of pefloxacin mesylate: comparison with conventional eye drops.
    Sultana Y; Aqil M; Ali A
    Drug Deliv; 2006; 13(3):215-9. PubMed ID: 16556574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolonged delivery of ciprofloxacin hydrochloride from hydrophilic ocular inserts.
    Samanta A; Ghosal SK
    Acta Pol Pharm; 2004; 61(5):343-9. PubMed ID: 15747690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and evaluation of ocular drug delivery system for controlled delivery of gatifloxacin sesquehydrate: In vitro and in vivo evaluation.
    Patel UL; Chotai NP; Nagda CD
    Pharm Dev Technol; 2012; 17(1):15-22. PubMed ID: 20649410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and evaluation of polymeric ocular drug delivery system.
    Gorle AP; Gattani SG
    Chem Pharm Bull (Tokyo); 2009 Sep; 57(9):914-9. PubMed ID: 19721251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation of in situ-forming ophthalmic gels of ciprofloxacin hydrochloride for the treatment of bacterial conjunctivitis: in vitro and in vivo studies.
    Charoo NA; Kohli K; Ali A
    J Pharm Sci; 2003 Feb; 92(2):407-13. PubMed ID: 12532390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ophthalmic delivery of ciprofloxacin hydrochloride from different polymer formulations: in vitro and in vivo studies.
    Charoo NA; Kohli K; Ali A; Anwer A
    Drug Dev Ind Pharm; 2003 Feb; 29(2):215-21. PubMed ID: 12648018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formulation and evaluation of ciprofloxacin hydrochloride soluble ocular drug insert.
    Mundada AS; Shrikhande BK
    Curr Eye Res; 2008 May; 33(5):469-75. PubMed ID: 18568884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The physicodynamic properties of mucoadhesive polymeric films developed as female controlled drug delivery system.
    Yoo JW; Dharmala K; Lee CH
    Int J Pharm; 2006 Feb; 309(1-2):139-45. PubMed ID: 16376036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of PVP/HPMC miscible blends with enhanced mucoadhesive properties for adjusting drug release in predictable pulsatile chronotherapeutics.
    Karavas E; Georgarakis E; Bikiaris D
    Eur J Pharm Biopharm; 2006 Aug; 64(1):115-26. PubMed ID: 16675210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative evaluation of plastic, hydrophobic and hydrophilic polymers as matrices for controlled-release drug delivery.
    Reza MS; Quadir MA; Haider SS
    J Pharm Pharm Sci; 2003; 6(2):282-91. PubMed ID: 12935440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A controlled-release ocular delivery system for ibuprofen based on nanostructured lipid carriers.
    Li X; Nie SF; Kong J; Li N; Ju CY; Pan WS
    Int J Pharm; 2008 Nov; 363(1-2):177-82. PubMed ID: 18706987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation and in vitro/in vivo evaluation of antimicrobial ocular in situ gels containing a disappearing preservative for topical treatment of bacterial conjunctivitis.
    Saher O; Ghorab DM; Mursi NM
    Pharm Dev Technol; 2016 Aug; 21(5):600-10. PubMed ID: 25886078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of sustained release gastroretentive drug delivery system for ofloxacin: in vitro and in vivo evaluation.
    Chavanpatil M; Jain P; Chaudhari S; Shear R; Vavia P
    Int J Pharm; 2005 Nov; 304(1-2):178-84. PubMed ID: 16198522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formulation and in vitro evaluation of cysteamine hydrochloride viscous solutions for the treatment of corneal cystinosis.
    Bozdağ S; Gümüş K; Gümüş O; Unlü N
    Eur J Pharm Biopharm; 2008 Sep; 70(1):260-9. PubMed ID: 18590953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gamma irradiated micro system for long-term parenteral contraception: An alternative to synthetic polymers.
    Puthli S; Vavia P
    Eur J Pharm Sci; 2008 Nov; 35(4):307-17. PubMed ID: 18760352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolonged release biodegradable vesicular carriers for rifampicin--formulation and kinetics of release.
    Kamath MP; Shenoy BD; Tiwari SB; Karki R; Udupa N; Kotian M
    Indian J Exp Biol; 2000 Feb; 38(2):113-8. PubMed ID: 11218826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel lipid-based formulations enhancing the in vitro dissolution and permeability characteristics of a poorly water-soluble model drug, piroxicam.
    Prabhu S; Ortega M; Ma C
    Int J Pharm; 2005 Sep; 301(1-2):209-16. PubMed ID: 16046087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.